NOVEMBER 2022LIFE SCIENCES REVIEW6Synthetic biology is an emerging field of science that deals with the design and construction of artificial biological systems for various applications. Due to the rising need for synthetic genes, proteins, and other biomolecules in the pharmaceutical and biotechnology industries, the synthetic biology market is anticipated to expand quickly. According to a new market analysis, the Synthetic Biology Market size was valued at $9.26 Billion in 2021 and is estimated to exceed $75.9 Billion in terms of revenue at a CAGR of 26.3 percent by 2030. Products produced by synthetic biology are used in pharmaceutical and biotechnology research, as well as industrial applications. Increasing government funding for synthetic biology research and the ever-expanding application areas of synthetic biology are the major drivers of this market. Synthetic biology has potential in DNA sequencing, genetic engineering, and other biotechnology applications. The discovery of new therapeutic proteins and designer microorganisms is expected to increase the demand for synthetic biology in the pharmaceutical and biotech sectors. Moreover, synthetic biology is used in the healthcare industry since it can aid in improving diagnostics and creating better treatment choices for a variety of diseases without having any negative side effects. For example, there is a significant rise in the use of genetically engineered viruses to correct defective genes in patients with inherited diseases like epidermolysis bullosa or severe combined immune deficiency (SCID).Apart from this, tools for performing synthetic biology are becoming more accessible, and internet penetration has enabled ideas and information to be freely exchanged. Rounding out, the expanding number of synthetic biology research entities are bringing a positive shift toward solving problems across the pharmaceutical and biotechnology sector. Let us know your thought.EDITORIALSynthetic Biology-Based Applications Making Way into Multiple ApplicationsCopyright © 2022 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com November - 14 - 2022, Vol 03, Issue - 22 Published by ValleyMedia, Inc. (ISSN 2831-8331)To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com Editorial StaffAaron PierceCarolynn WaltersGiftson JoshuaJoe Philip Shirley FaithRussell ThomasVisualizersRonald DonovanDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsAsher Blake
< Page 5 | Page 7 >